EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo

Svenja Royeck, Henning Olbrich iD, Steffen Koschmieder, Claudia Zeidler iD, Felix Witte iD, Konstantin Agelopoulos, Henning Wiegmann, Michael Storck iD, Johannes Benedict Oehm, Ralf J Ludwig, Sonja Ständer iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2026-11 · 24 (11) · 1588-1596

DOI: 10.1111/ddg.70057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 06.04.2026. Verfasst von Svenja Royeck und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section Pruritus Medicine, Department of Dermatology and Center for Chronic Pruritus (KCP), University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Prurigo, Pruritus, Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital Schleswig-Holstein, Cluster of Excellence "Precision Medicine in Chronic Inflammation".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Chronic pruritus (CP) and chronic prurigo (CPG, including prurigo nodularis) are prevalent, debilitating diseases with diverse comorbidities, including malignancies. This retrospective cohort study evaluated the prevalence and risk of lymphoma in CP and CPG patients, including key risk factors, and sex‐ and ancestry‐related disparities. Patients and methods We utilized electronic health records from the TriNetX US Collaborative Network (2011–2024), including 1,032,281 CP and 124,611 CPG patients (without prior lymphoma), matched to non‐CP/non‐CPG controls. Lymphoma risk was evaluated up to 5 years post‐diagnosis. Sensitivity, sex‐ and ancestry‐stratified analyses were performed. Multivariate analyses identified risk factors.

Results

Lymphoma developed in 0.29 % of CP (controls: 0.10 %, HR 2.90, 95 % 95 % CI: 2.71–3.12) and 0.30 % of CPG patients (controls: 0.10 %, HR 2.85, 95 % CI: 2.33‐3.48; both p < 0.0001). The HR for cutaneous lymphoma was 6.62 (95 % CI 5.02–8.72) for CP and 10.95 (95 % CI 4.39–27.35) for CPG (p < 0.0001 each). Findings remained robust across all sensitivity analyses. Significant lymphoma risk factors included elevated serum lactate dehydrogenase, beta 2‐microglobulin, male sex, immunosuppressant use, and White ancestry.

Conclusions

CP and CPG patients have an increased lymphoma risk, linked to specific biomarkers, highlighting the importance of increased clinical vigilance in their management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrurigoPruritusLymphomaHumansMaleFemaleRisk FactorsChronic DiseaseMiddle AgedPrevalenceComorbidityRetrospective StudiesAgedAdultUnited StatesRisk Assessment

Stichwörter der Autor:innen

TriNetXchronic prurigochronic prurituscohort studylymphomareal‐world data

Autor:innen und Institutionen

  • Section Pruritus Medicine, Department of Dermatology and Center for Chronic Pruritus (KCP), University Hospital Münster, Münster, Germany.
  • Department of Dermatology, University-Hospital Schleswig-Holstein (UKSH), Lübeck, Germany.
  • Department of Haematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
  • Institute of Medical Informatics, University of Münster, Münster, Germany.
  • Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

ORCID-Profile: Henning Olbrich, Claudia Zeidler, Felix Witte, Michael Storck, Sonja Ständer

Förderung

  • University Hospital Schleswig-Holstein
  • Cluster of Excellence "Precision Medicine in Chronic Inflammation"

Zitieren

APA

Royeck, S., Olbrich, H., Koschmieder, S., Zeidler, C., Witte, F., Agelopoulos, K., Wiegmann, H., Storck, M., Oehm, J. B., Ludwig, R. J., & Ständer, S. (2026). Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 24(11), 1588-1596. https://doi.org/10.1111/ddg.70057

Vancouver

Royeck S, Olbrich H, Koschmieder S, Zeidler C, Witte F, Agelopoulos K, et al. Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026;24(11):1588-1596. doi:10.1111/ddg.70057

BibTeX
@article{Royeck2026,
  author = {Royeck, Svenja and Olbrich, Henning and Koschmieder, Steffen and Zeidler, Claudia and Witte, Felix and Agelopoulos, Konstantin and Wiegmann, Henning and Storck, Michael and Oehm, Johannes Benedict and Ludwig, Ralf J and Ständer, Sonja},
  title = {Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2026},
  volume = {24},
  number = {11},
  pages = {1588--1596},
  doi = {10.1111/ddg.70057}
}
Kostenlos starten →